Alnylam Pharmaceuticals, Inc.

Insider Trading: Sales
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
RGLS $16.29 446 Large Shareholder 5,896,716 2014-10-24 Filing
RGLS $15.50 350 Large Shareholder 5,897,162 2014-10-24 Filing
RGLS $14.63 1,054 Large Shareholder 5,897,512 2014-10-24 Filing
RGLS $15.45 50 Large Shareholder 5,898,566 2014-10-23 Filing
RGLS $14.90 450 Large Shareholder 5,898,616 2014-10-23 Filing
RGLS $13.94 1,200 Large Shareholder 5,899,066 2014-10-23 Filing
RGLS $17.11 175 Large Shareholder 5,900,266 2014-10-22 Filing
RGLS $16.59 11,376 Large Shareholder 5,900,441 2014-10-22 Filing
RGLS $14.67 15,156 Large Shareholder 5,911,817 2014-10-22 Filing
RGLS $13.91 57,753 Large Shareholder 5,926,973 2014-10-22 Filing
RGLS $12.83 15,791 Large Shareholder 5,984,726 2014-10-22 Filing
RGLS $12.18 9,283 Large Shareholder 6,000,517 2014-10-22 Filing
RGLS $15.19 1,850 Large Shareholder 5,896,716 2014-10-24 Filing
RGLS $14.24 1,700 Large Shareholder 5,898,566 2014-10-23 Filing
RGLS $14.00 109,534 Large Shareholder 5,900,266 2014-10-22 Filing
RGLS $6.79 3,000 Large Shareholder 6,009,800 2014-10-17 Filing
RGLS $6.76 4,800 Large Shareholder 6,012,800 2014-10-16 Filing
RGLS $6.67 4,300 Large Shareholder 6,017,600 2014-10-15 Filing
RGLS $6.41 2,000 Large Shareholder 6,021,900 2014-10-10 Filing
RGLS $6.58 4,750 Large Shareholder 6,023,900 2014-10-09 Filing